A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII)

References

• Adams D. D., Purves H. D. Abnormal responses in the assay of thyrotropin. Proc. Unniv. Otago Med. School 1956; 34: 11
   Google Scholar
• Adams D. D., Kennedy T. H. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J. clin. Endocr. Meiab 1967; 27: 173
   PubMed Web of Science ®Google Scholar
• Beall G. N., Chopra L J., Solomon D. H., Irvine W. J., Kruger S. R. Studies of the TSH radio-receptor assay. Acta Endocr 1979; 90: 217
   PubMedGoogle Scholar
• Bech K., Madsen S. N. Human thyroid adenylate cyclase in non-toxic goitre: sensitivity to TSH, fluoride and thyroid stimulating immunoglobulins. Clin. Endocr 1978; 8: 457
   PubMedGoogle Scholar
• Berson S. A., Yalow R. S. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J. clin. Invest 1959; 39: 1996
   Google Scholar
• Bolk J. H., Bussemaker J. K., Elte J. W.F., Haak A., van der Heide D. Thyroid-stimulating immunoglobulins do not cause non-autonomous, autonomous or toxic multinodular goitres. Lancet 1979; ii: 61
   Google Scholar
• Brown R. S., Pohl S. L., Jackson I. M.D., Reichlin S. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?. Lancet 1978; i: 904
   Google Scholar
• Bryson J. M., Joasoo A., Turtle J. R. The thyrotropin receptor in human thyroid plasma membranes, effect of serum immunoglobulins. Acta Endocr 1976; 83: 528
   PubMedGoogle Scholar
• Clague R., Mukhtar E. D., Pyle G. A., Nutt J., Clark F., Scott M., Evered D., Smith B. R., Hall R. Thyroid-stimulating immunoglobulins and the control of thyroid function. J. clin. Endocr. Metah 1976; 43: 550
   PubMedGoogle Scholar
• Doctor R., Bos G., Visser T. J., Hennemann G. Thyrotropin binding inhibiting immunoglobulins in Graves' disease before, during and after anti-thyroid therapy, and its relation to long acting thyroid stimulator. Clin. Endocr 1980; 12: 143
   PubMedGoogle Scholar
• 11 Editorial. Four controversies about the cause of hyperthyroidism. Lancer 1979; ii: 78
   Google Scholar
• Endo K., Kasagi K., Konishi J., Ikekubo K., Okuno T., Takeda Y., Mori T., Torizuka K. Detection and properties of TSH-binding inhibitor immunoglobulins in oatients with Graves' disease and Hasrhimoto's thyroiditis. J. clin. Endoer. Metab 1978; 46: 734
   PubMed Web of Science ®Google Scholar
• Fenzi G., Hashizume K., Roudebush P., De Groot L. J. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J. clin. Endocr. Metab 1979; 48: 572
   PubMedGoogle Scholar
• Friis T. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos. Danish Med. Bull 1969; 16: 294
   PubMedGoogle Scholar
• Hunter W. M., Greenwood F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495
   PubMed Web of Science ®Google Scholar
• Kirkegaard C., Friis T., Siersbaek-Nielsen K. Measurements of serum tri-iodothyronine by radioimmunoassay. Acta Endoer 1974; 77: 71
   PubMedGoogle Scholar
• Koelendorf K., Moeller B. B., Rogowski P. The influence of chronic renal failure on serum and urinary thyroid hormone levels. Acta Endoer 1978; 89: 80
   PubMedGoogle Scholar
• Lamberg B.-A., Gordin A., Viherskoski M., Kvist G. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease. Acta Endocr 1969; 62: 199
   PubMedGoogle Scholar
• Laurell C.-B. Electroimmunoassay. Scand. J. clin. Lab. Invest 1972; 29: 21, 124, suppl.
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. biol. Chem 1951; 193: 265
   PubMed Web of Science ®Google Scholar
• Mc Kenzie J. M. The bioassay of thyrotropin in serum. Endocrinology 1958; 63: 372
   PubMed Web of Science ®Google Scholar
• Mehdi S. Q., Nussey S. S. A radio-ligand receptor assay for the long-acting thyroid stimulator. Biochem. J 1975; 145: 105
   PubMed Web of Science ®Google Scholar
• Mukhtar E. D., Pyle G. A., Smith B. R., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine and antithyroid drugs. Lancet 1975; i: 713
   Google Scholar
• O'Donnell J., Trokoudes K., Silverberg J., Row V., VolpB R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J. clin. Endocr. Metab 1978; 46: 770
   PubMedGoogle Scholar
• Orgiazzi J., Williams D. E., Chopra I. J., Solomon D. H. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. J. clin. Endocr. Metab 1976; 42: 341
   PubMedGoogle Scholar
• Pekary A. E., Hershman J. M., Parlow A. F. A sensitive and precise radioimmunoassay for human thyroid-stimulating hormone. J. clin. Endocr. Metab 1975; 41: 676
   PubMed Web of Science ®Google Scholar
• Schleusener H., Kotulla P., Finke R., Sorje H., Meinhold H., Adlkofer F., Wenzel K. W. Relationship between thyroid states and Graves' disease specific immunoglobulins. J. clin. Endocr. Metab 1978; 47: 379
   PubMed Web of Science ®Google Scholar
• Smith B. R., Hall R. Thyroid-Stimulating Immunoglobulins in Graves' disease. Lancet 1974; ii: 427
   Google Scholar
• Smith B. R., Hall R. Binding of thyroid stimulators to thyroid membranes. FEES Lett 1974; 42: 301
   PubMedGoogle Scholar
• Takasu N., Sato S., Tsukui T., Yamada T., Furihata R., Makiuchi M. Inhibitory action of thyroid hormone on the activation of adenyl cyclase-cyclic AMP system by thyroid-stimulating hormone in human thyroid tissues from euthyroid subjects and thyrotoxic patients. J. clin. Endocr. Metab 1974; 39: 772
   PubMed Web of Science ®Google Scholar
• Yu S., Friedman Y., Richman R., Burke G. Altered thyroidal responsivity to thyrotropin induced by circulating thyroid hormones. J. clin. Invest 1976; 57: 745
   PubMed Web of Science ®Google Scholar